497.05

+2.64%↑

SANES

10.984

+4.23%↑

SAF

315.8

+5.41%↑

BBVA

20.28

+3.79%↑

BNP

94.03

+3.79%↑

497.05

+2.64%↑

SANES

10.984

+4.23%↑

SAF

315.8

+5.41%↑

BBVA

20.28

+3.79%↑

BNP

94.03

+3.79%↑

497.05

+2.64%↑

SANES

10.984

+4.23%↑

SAF

315.8

+5.41%↑

BBVA

20.28

+3.79%↑

BNP

94.03

+3.79%↑

497.05

+2.64%↑

SANES

10.984

+4.23%↑

SAF

315.8

+5.41%↑

BBVA

20.28

+3.79%↑

BNP

94.03

+3.79%↑

497.05

+2.64%↑

SANES

10.984

+4.23%↑

SAF

315.8

+5.41%↑

BBVA

20.28

+3.79%↑

BNP

94.03

+3.79%↑

Home・Aandelen Lijst・Synergie SA.

Synergie SA.

Gesloten

28.2 0.36

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

28.2

Max

28.7

Belangrijke statistieken
By Trading Economics
Inkomsten	27M
Verkoop	74M 1.7B
K/W Sectorgemiddelde	11.983 37.733
Dividendrendement	1.77
Winstmarge	1.718
Werknemers	5,350
EBITDA	-16B -1.5B

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	1.77% 4.63%

Marktinformatie
By TradingEconomics
Marktkapitalisatie	20M 646M
Vorige openingsprijs	27.84
Vorige sluitingsprijs	28.2

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

30.5 / N/A Steun & Weerstand

Synergie SA. Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 apr 2026, 20:26 UTC

Acquisities, Fusies, Overnames

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17 apr 2026, 18:15 UTC

Belangrijke Nieuwsgebeurtenissen

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17 apr 2026, 16:49 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17 apr 2026, 16:49 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17 apr 2026, 22:58 UTC

Winsten

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 apr 2026, 21:32 UTC

Marktinformatie

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 apr 2026, 21:22 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 apr 2026, 21:22 UTC

Marktinformatie

Moody's Downgrades Belgium to A1 -- Market Talk

17 apr 2026, 20:52 UTC

Winsten

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 apr 2026, 20:50 UTC

Marktinformatie

Winsten

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

17 apr 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

17 apr 2026, 20:29 UTC

Winsten

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17 apr 2026, 20:11 UTC

Acquisities, Fusies, Overnames

UCB to Buy Neurona Therapeutics for Up to $1.15B

17 apr 2026, 19:34 UTC

Marktinformatie

Winsten

Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

17 apr 2026, 19:34 UTC

Marktinformatie

Winsten

Acquisities, Fusies, Overnames

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17 apr 2026, 19:31 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17 apr 2026, 19:26 UTC

Marktinformatie

U.S. Natural Gas Futures Edge Up -- Market Talk

17 apr 2026, 19:21 UTC

Marktinformatie

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17 apr 2026, 19:15 UTC

Marktinformatie

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 apr 2026, 19:07 UTC

Marktinformatie

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 apr 2026, 18:57 UTC

Belangrijke Nieuwsgebeurtenissen

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17 apr 2026, 18:53 UTC

Acquisities, Fusies, Overnames

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17 apr 2026, 18:53 UTC

Acquisities, Fusies, Overnames

UCB 2026 Rev Guidance Unchanged

17 apr 2026, 18:52 UTC

Acquisities, Fusies, Overnames

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17 apr 2026, 18:52 UTC

Acquisities, Fusies, Overnames

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17 apr 2026, 18:14 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17 apr 2026, 18:00 UTC

Belangrijke Nieuwsgebeurtenissen

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17 apr 2026, 18:00 UTC

Belangrijke Nieuwsgebeurtenissen

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17 apr 2026, 17:31 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17 apr 2026, 17:26 UTC

Marktinformatie

Winsten

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Peer Vergelijking

Prijswijziging

Synergie SA. Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Synergie SA. - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

30.5 / N/ASteun & Weerstand

Recent bullish events outweigh bearish events.

Financieel

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Synergie SA.

Synergie SE provides human resources management and development services for companies and institutions in France, Belgium, Other Northern and Eastern Europe, Italy, Spain, Portugal, Canada, and Australia. It offers temporary work, recruitment, out-placement, social engineering, consultancy, and training services. The company serves various specialized sectors and industries, such as renewable energy, transport and logistics, construction and public works, healthcare, agri-food, and tertiary sectors. Synergie SE was founded in 1969 and is headquartered in Paris, France.